Gastrointestinal adverse events associated with SNRIs: A FAERS-based pharmacovigilance study
- 27 May 2025
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 387, 119484
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82200616, 82204655)
- Traditional Chinese Medicine Bureau of Guangdong Province (20231082)
- Innovative Research Group Project of the National Natural Science Foundation of China
- Guangdong Provincial Medical Research Foundation (A2022047)
This publication has 43 references indexed in Scilit:
- Management of Depression in AdultsJAMA, 2024
- Adverse Effects of Antidepressant Medications and their Management in Children and AdolescentsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023
- The gut-to-brain axis for toxin-induced defensive responsesCell, 2022
- Mixed lymphocytic and collagenous inflammation of the entire gastrointestinal tract under therapy with serotonin and norepinephrine reuptake inhibitorsVirchows Archiv, 2022
- Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and TreatmentCNS Drugs, 2021
- Understanding the Connection Between the Gut–Brain Axis and Stress/Anxiety DisordersCurrent Psychiatry Reports, 2021
- The Gut Microbiota and Unhealthy Aging: Disentangling Cause from ConsequenceCell Host & Microbe, 2020
- Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and AdolescentsJAMA Psychiatry, 2017
- In vivo studies of effects of antidepressants on parotid salivary secretion in the ratArchives of Oral Biology, 2016
- Impact of age on serum concentrations of venlafaxine and escitalopram in different CYP2D6 and CYP2C19 genotype subgroupsEuropean Journal of Clinical Pharmacology, 2014